{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:17:52Z","timestamp":1792603072610,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"vor","delay-in-days":1890,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.fertnstert.2018.07.024","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T02:25:07Z","timestamp":1543544707000},"page":"1398-1407.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production"],"prefix":"10.1016","volume":"110","author":[{"given":"Minnie","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Britten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Borahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Segars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Catherino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2018.07.024_bib1","doi-asserted-by":"crossref","first-page":"2414609","DOI":"10.1155\/2018\/2414609","article-title":"A comprehensive review of the pharmacologic management of uterine leiomyoma","volume":"2018","author":"Lewis","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib3","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.12688\/f1000research.12172.1","article-title":"Uterine fibroids\u2014what\u2019s new?","volume":"6","author":"Williams","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-0037-1606569","article-title":"Uterine leiomyoma: new perspectives on an old disease","volume":"35","author":"Segars","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1177\/1933719114546644","article-title":"Uterine fibroid research: a work in progress","volume":"21","author":"Segars","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10815-012-9784-0","article-title":"Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances","volume":"29","author":"Levy","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0030-1251475","article-title":"Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women","volume":"28","author":"Malik","year":"2010","journal-title":"Sem Reprod Med"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2119\/molmed.2014.00053","article-title":"Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy","volume":"21","author":"Borahay","year":"2015","journal-title":"Mol Med"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5468\/ogs.2018.61.2.192","article-title":"Current medical treatment of uterine fibroids","volume":"61","author":"Sohn","year":"2018","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","article-title":"A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays","volume":"195","author":"Leppert","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/humupd\/dmv030","article-title":"Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth","volume":"21","author":"Commandeur","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib12","first-page":"130","article-title":"Uterine fibroids review: Understanding their origins to better understand their future treatments","volume":"3","author":"Botia","year":"2017","journal-title":"J Tumor Res"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids and breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib14","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.fertnstert.2010.04.065","article-title":"Reproductive characteristics and risk of uterine leiomyoma","volume":"94","author":"Terry","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib15","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/GCO.0b013e32833e49b0","article-title":"Risk of pelvic organ fistula in patients undergoing hysterectomy","volume":"22","author":"Forsgren","year":"2010","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00192-011-1523-z","article-title":"Vaginal hysterectomy and risk of pelvic organ prolapse and stress urinary incontinence surgery","volume":"23","author":"Forsgren","year":"2012","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib18","first-page":"631","article-title":"Statin therapy: review of safety and potential side effects","volume":"32","author":"Ramkumar","year":"2016","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib19","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib20","first-page":"64","article-title":"Cholesterol and mevalonic acid modulation in cell metabolism and multiplication","author":"Soma","year":"1992","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/pros.20951","article-title":"Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations","volume":"69","author":"Murtola","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2011.10.022","article-title":"Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL","volume":"673","author":"Murtola","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib23","doi-asserted-by":"crossref","first-page":"e110231","DOI":"10.1371\/journal.pone.0110231","article-title":"Statin use and breast cancer survival: a nationwide cohort study from Finland","volume":"9","author":"Murtola","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib24","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1111\/cas.13570","article-title":"Activation of AMPK by simvastatin inhibited breast tumor angiogenesis via impeding HIF-1\u03b1-induced pro-angiogenic factor","volume":"109","author":"Wang","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/1933719117750751","article-title":"Therapeutic roles of statins in gynecology and obstetrics: the current evidence","volume":"25","author":"Zeybek","year":"2018","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1933719115584446","article-title":"Statins as targeted \u201cmagical pills\u201d for the conservative treatment of endometriosis: may potential adverse effects on female fertility represent the \u201cdark side of the same coin\u201d? A systematic review of literature","volume":"23","author":"Vitagliano","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib27","doi-asserted-by":"crossref","first-page":"35075","DOI":"10.1074\/jbc.M114.583575","article-title":"Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells","volume":"289","author":"Borahay","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib28","doi-asserted-by":"crossref","first-page":"196.e1","DOI":"10.1016\/j.ajog.2015.03.055","article-title":"Novel effects of simvastatin on uterine fibroid tumors: in\u00a0vitro and patient-derived xenograft mouse model study","volume":"213","author":"Borahay","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib29","doi-asserted-by":"crossref","first-page":"750.e1","DOI":"10.1016\/j.ajog.2016.06.036","article-title":"Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study","volume":"215","author":"Borahay","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12967-018-1430-x","article-title":"The role of atorvastatin in suppressing tumor growth of uterine fibroids","volume":"16","author":"Shen","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2125.2011.03907.x","article-title":"What is a relevant statin concentration in cell experiments claiming pleiotropic effects?","volume":"72","author":"Bjorkhem-Bergman","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jfda.2013.05.003","article-title":"Determination of serum atorvastatin concentrations in lipid-controlling patients with and without myalgia syndrome","volume":"21","author":"Chou","year":"2013","journal-title":"J Food Drug Anal"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib33","doi-asserted-by":"crossref","first-page":"III-32","DOI":"10.1002\/clc.4960261507","article-title":"Pharmacologic characteristics of statins","volume":"26","author":"McKenny","year":"2003","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2265.2008.03207.x","article-title":"Retinoic acid treatment of human cells transformed the cell phenotype to one strongly resembling myometrial cells","volume":"69","author":"Malik","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.fertnstert.2012.02.037","article-title":"Development and validation of a three-dimensional in\u00a0vitro model for uterine leiomyoma and patient-matched myometrium","volume":"97","author":"Malik","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib36","doi-asserted-by":"crossref","first-page":"e1970","DOI":"10.21769\/BioProtoc.1970","article-title":"A 3D culture system of human immortalized myometrial cells","volume":"6","author":"Malik","year":"2016","journal-title":"Bio Protoc"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib37","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.fertnstert.2015.09.006","article-title":"Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones","volume":"105","author":"Malik","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jcp.50.10.801","article-title":"European Organization for Research and Treatment of Cancer\u2013Gynaecological Cancer Cooperative Group. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG","volume":"50","author":"van Diest","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/CS20150027","article-title":"Cellular and molecular mechanisms of statins: an update on pleiotropic effects","volume":"129","author":"Satoh","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib41","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.febslet.2012.02.032","article-title":"Molecular switches in animal cells","volume":"586","author":"H\u00f6rner","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib42","doi-asserted-by":"crossref","first-page":"e53882","DOI":"10.1371\/journal.pone.0053882","article-title":"A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation","volume":"8","author":"van der Meij","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.111.004994","article-title":"Pharmacological actions of statins: a critical appraisal in the management of cancer","volume":"64","author":"Gazzerro","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yexcr.2017.02.034","article-title":"The mevalonate pathway in neurons: It\u2019s not just about cholesterol","volume":"360","author":"Moutinho","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib46","doi-asserted-by":"crossref","first-page":"474.e1","DOI":"10.1016\/j.ajog.2007.11.057","article-title":"Mechanical homeostasis is altered in uterine leiomyoma","volume":"198","author":"Rogers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.matbio.2011.09.001","article-title":"Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma","volume":"31","author":"Norian","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.matbio.2012.09.005","article-title":"Integrin \u03b21 regulates leiomyoma cytoskeletal integrity and growth","volume":"31","author":"Malik","year":"2012","journal-title":"Matrix Biol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib49","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1073\/pnas.1215759110","article-title":"Loss of the repressor REST in uterine fibroids promotes aberrant G protein\u2013coupled receptor 10 expression and activates mammalian target of rapamycin pathway","volume":"110","author":"Varghese","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2015.11.018","article-title":"The epidemiology and genetics of uterine leiomyoma","volume":"34","author":"Styer","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2006.03.003","article-title":"Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions","volume":"112","author":"Shitara","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib52","first-page":"528376","article-title":"The natural history of uterine leiomyomas: light and electron microscopic studies of fibroid phases, interstitial ischemia, inanosis, and reclamation","volume":"2013","author":"Flake","year":"2013","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.fertnstert.2018.07.024_bib53","unstructured":"Britten J, Malik M, Lewis TD, Catherino WH. Ulipristal acetate mediates proteoglycan degradation through regulation of nuclear factor of activated T-cells (NFAT5). Reprod Sci. In press."}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028218306162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028218306162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:21:15Z","timestamp":1758010875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028218306162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0015028218306162"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2018.07.024","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2018.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92018 Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine","name":"copyright","label":"Copyright"}]}}